Background {#Sec1}
==========

Recurrence after radiotherapy of prostate carcinoma often originates from a macroscopic intraprostatic lesion (IPL). A simultaneous integrated boost (SIB) to the dominant IPL is a strategy to fight such recurrences \[[@CR1]--[@CR4]\]. Toxicity seems to be less of a problem \[[@CR5]--[@CR8]\], however it has been suggested that intrafraction motion requires either intrafraction motion tracking in case of small margins \[[@CR9]\] or substantial margins \[[@CR10]\].

Generally, the recording of the prostate position by 4D ultrasound \[[@CR11]\] or kV-imaging \[[@CR12], [@CR13]\] during a fraction has received some interest in recent years and is a natural extension of these techniques from inter-fraction position verification and correction to online intra-fraction monitoring and adaption. The hope is, e.g. to account for prostate intra-fraction motion by gating the beam or tracking the prostate by continually adjusting the multi-leaf collimator \[ [@CR14]--[@CR17]\].

In this simulation study we calculate the impact of intrafraction motion on the volumetric coverage between IPL and SIB and on dose volume histograms (DVH). We use motion data from real time ultrasound tracking during actual fractions and apply this data to idealized spherical IPL volumes of 3, 5, and 7 mm radius and to idealized spherical SIB volumes without and with safety margins of 2 mm resp. 5 mm.

Our main question is, if and what size of margins is required to counterbalance intrafraction motion and ensure an acceptable dose coverage of the IPL.

Methods {#Sec2}
=======

Intrafraction motion data {#Sec3}
-------------------------

The analysis is based on the same set of patients and raw data as reported in \[[@CR18]\]. The study is based on 28 patients with adenocarcinoma of the prostate who received a definitive external beam radiotherapy between June 2014 and March 2017 at our department. The 28 patients were of a typical demographics for prostate cancer, as were the treatment regimes, see Table [1](#Tab1){ref-type="table"}.Table 1Patient demographics and treatment regimesNumber of patients28Fractions recorded720Duration recorded53 h 32 m 59 sAge (years)median: 72.4 range: 53.2 to 85.9Body size (cm)median: 178 range: 163 to 195Body weight (kg)median: 82 range: 63 to 106Prostate volume (ml)median: 45 range: 15 to 90T (%)T1--13 (46%) T2--10 (36%) T3--5 (18%)Number of fractions35--1 (4%) 36--5 (18%) 37--10 (36%) 38--12 (43%)Total dose (Gy)median: 74.0 avg. ± std.: 74.4 ± 1.7 range: 70.0 to 76.0

Up to the calculation of prostate trajectories, the raw data and methods were identical to those detailed in \[[@CR18]\].

Vertical (anterior-posterior), longitudinal (cranial-caudal), lateral (left-right), and radial ('vector length' or Euclidean '3D distance') prostate displacements were calculated relative to the starting position of the prostate (as recorded by 4DUS) after image guide repositioning (by kV-CBCT) at the beginning of the respective fraction.

Averages, standard deviations, quantiles (5, 25%, median, 75, and 95%) and root mean squares (r.m.s.) of vertical, longitudinal, lateral, and radial displacements were calculated.

Volumetric coverage {#Sec4}
-------------------

The IPL was idealized as a sphere of radius r. The dose distribution was idealized as constant within a spherical region of radius r + m and zero outside, where m denotes the safety margin. These idealizations were assumed for simplicity, and because they are not uncommon, e.g. in optimal margin recipes.

The 3D-distance or Euclidean distance d of the prostate from the origin determined the distance of the centers of these two spheres. The volume of the overlap of the two spheres in case m \< d \< r + m was.$$\documentclass[12pt]{minimal}
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See Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Calculation of the overlap between SIB dose and IPL volume

This volume was divided by the volume of the IPL, V~IPL~ = 4π/3 \* r^2^ to arrive at the coverage.$$\documentclass[12pt]{minimal}
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This coverage c~IPL,i~ was calculated for every single one of the 39,295 measured 3D-distances d~i~ and for every combination of IPL radius r (3 mm, 5 mm, 7 mm) and safety margin m (0 mm, 2 mm, 5 mm). Finally, the respective averages, standard deviations, quantiles (5, 25%, median, 75, and 95%) over all measurements were calculated.

The aforementioned coverage of the IPL volume by the SIB volume, in % of IPL volume, concerns the question how much dose was received by the IPL. The other interesting question is how much of the overall SIB dose was received by the IPL. To this end, the coverage c~SIB~ of the larger SIB volume by the smaller IPL volume, in % of SIB volume, was also calculated. This 'reverse' calculation yields:
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Dose volume histograms {#Sec5}
----------------------

For the calculation of DVHs, 5000 points within the IPL sphere of radius r were randomly and uniformely sampled (Monte Carlo). The points were parametrized as a triple (a, b, c). For each measured position (x~i~,y~i~,z~i~) of the prostate, it was checked if (a + x~i~)^2^ + (b + y~i~)^2^ + (c + z~i~)^2^ \< = (r + m)\^2 lay within the sphere covered by the SIB. If so, a unit of dose was added, and the received units of dose were divided by the number of samples, 39,925. Each of these dose percentages was then added to the histogram of 5000 such dose percentages which was plotted as the DVH. Again, this procedure was done for every combination of IPL radius r (3 mm, 5 mm, 7 mm) and safety margin m (0 mm, 2 mm, 5 mm).

Data handling, statistical analysis and plots were performed with Microsoft Excel and VBA.

Results {#Sec6}
=======

Intrafraction motion data {#Sec7}
-------------------------

On average over all patients and fractions, the prostate was displaced by about 1.3 mm radially from its initial position. In some cases, the prostate drifted off by 1 cm or more, but during 95% of the time, it remained within 4.3 mm of its initial position, see Table [2](#Tab2){ref-type="table"}.Table 2Recorded displacements of the prostate from its initial positionLongitudinal displacementLateral displacementVertical displacementEuclidean 3D distanceAverage−0.130.000.111.28Std.dev.1.150.761.641.72Minimum−13.11−11.43−7.400.005% quantile−1.87−0.94−1.780.1225% quantile−0.27−0.19− 0.510.37Median0.020.00−0.100.7375% quantile0.300.220.341.4995% quantile1.150.902.884.26Maximum6.038.8717.5221.20Displacements of the prostate from its initial position along different axes. All units are mm

Volumetric coverage {#Sec8}
-------------------

Even without safety margins, a same-sized SIB would have covered 73, 82% resp. 87% of the volume of an IPL of radius 3 mm, 5 mm resp. 7 mm, on average. 95% of the time, it would have covered at least 11, 40% resp. 56% of the IPL volume. These numbers improve substantially for a moderately sized safety margin of 2 mm. In this case, average coverage would have been at least 95, and 95% of the time (and hence, dose) would have been applied to a majority of the IPL volume. Furthermore, with 5 mm safety margin, average coverage would be around 99, and 95% of the time the SIB would have completely covered the IPL volume. See Table [3](#Tab3){ref-type="table"}.Table 3Volumetric coverage c~IPL~ of the IPL by the SIB, in % of IPL volumeSafety marginnone2 mm5 mmIPL radius3 mm5 mm7 mm3 mm5 mm7 mm3 mm5 mm7 mmAverage73%82%87%95%96%97%98%99%99%Std.dev.25%19%15%18%14%11%11%8%6%Minimum0%0%0%0%0%0%0%0%0%5% quantile11%40%56%57%76%84%100%100%100%25% quantile63%78%84%100%100%100%100%100%100%Median82%89%92%100%100%100%100%100%100%75% quantile91%95%96%100%100%100%100%100%100%95% quantile97%98%99%100%100%100%100%100%100%Maximum100%100%100%100%100%100%100%100%100%Percentage c~IPL~ of the IPL volume that is covered by the SIB volume

Safety margins, however, would also have had a downside in terms of dose efficiency resp. potentially toxicity. Due to the cubic power in the ratio between IPL volume (proportional to r\^3) and SIB volume (proportional to (r + m)\^3) the ratio would have fallen off quickly even in the best case of completely overlapping spheres. For example, in case of a 2 mm margin for a 5 mm radius lesion, the volume of the IPL would have been only 36% of the SIB, with two thirds of the boost dose going to surrounding non-lesion prostate tissue or even non-prostate tissue. The percentage of SIB dose that would have gone to the IPL is shown in Table [4](#Tab4){ref-type="table"} for the different situations.Table 4Volumetric coverage c~SIB~ of the SIB by the IPL, in % of SIB volumeSafety marginnone2 mm5 mmIPL radius3 mm5 mm7 mm3 mm5 mm7 mm3 mm5 mm7 mmAverage73%82%87%20%35%46%5%12%20%Std.dev.25%19%15%4%5%5%1%1%1%Minimum0%0%0%0%0%0%0%0%0%5% quantile11%40%56%12%28%40%5%13%20%25% quantile63%78%84%22%36%47%5%13%20%Median82%89%92%22%36%47%5%13%20%75% quantile91%95%96%22%36%47%5%13%20%95% quantile97%98%99%22%36%47%5%13%20%Maximum100%100%100%22%36%47%5%13%20%Percentage c~SIB~ of the SIB volume that is covered by the IPL volume

Dose volume histograms {#Sec9}
----------------------

The dose volume histograms draw a slightly more differentiated picture, see Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Dose volume histograms. Cumulative histogram of the dose volume relationship with dose on the horizontal axis (in percentage of maximum dose) and volume on the vertical axis (in percentage of IPL volume). Result of Monte Carlo simulations for different combinations of IPL radius (3 5 and 7 mm) and SIB safety margin (0 2 and 5 mm)

In all situations, 30% of the dose would have been received by 100% of the IPL volume, with our without safety margins.

Without safety margins, 50% of the dose would have been received by 91, 96% resp. 98% of the IPL volume of radius 3 mm, 5 mm resp. 7 mm. With safety margins of either 2 mm or 5 mm, that 50% dose would have been received by 100% of the IPL volume.

At 95% of dose, the size of the safety margin begins to matter. An IPL volume of 3 mm receives 0% (no safety margins), 42% (2 mm safety margin) resp. 100% (5 mm safety margin) of the dose. Similarly, the dose received by an IPL volume of 5 mm increases from 9% (no safety margin) to 83% (2 mm) to 100%. In case of an IPL volume of 7 mm, this receives already 31% of dose without any safety margins, and this value increases to 90% in case of 2 mm margins. See in the Additional file [1](#MOESM1){ref-type="media"}: Table S5."Conversely, e.g. 95% of the IPL volume of radius 3 mm, 5 mm resp. 7 mm receive 44, 53% resp. 58% of the nominal SIB dose in the absence of safety margins. This percentage rises to over 90% in case of 2 mm margins and to 98% in case of 5 mm margins. These figures can be recovered by scaling the earlier results by (r + m)^3^/r^3^, as explained above."

Patient variability {#Sec10}
-------------------

The motility of the prostate differs in patients. While the average radial displacement of the prostate was 1.28 mm across all patients and fractions, it was as small as 0.50 mm in one patient (patient \#13) and as large as 2.53 mm in another (patient \#11). The median was 1.06 mm with quartiles 0.75 mm and 1.39 mm. Similarly, the maximum radial displacement of the prostate was only 2.68 mm in one patient (patient \#27) and as large as 21.20 mm in another (patient \#10). The median was 7.82 mm with quartiles 4.96 mm and 10.07 mm. These differences translate into the DHVs. To illustrate the two extreme cases, Fig. [3](#Fig3){ref-type="fig"} shows the DVHs for patients \#13 and \#11 side by side:Fig. 3Dose volume histograms for individual patients (extreme cases of minimal and maximal motility). As Fig. [1](#Fig1){ref-type="fig"} but for individual patients. **a** The top plot shows the DVHs for patient \#13 who featured a particular small average radial displacement of the prostate of 0.50 mm. **b** By contrast the bottom plot shows the DVHs for patient \#11 with a particularly large average radial displacement of the prostate of 2.53 mm

Discussion {#Sec11}
==========

A recent review on IPL boosts \[[@CR3]\] reports a mean of 2.4 cm^3^ for the mean/median IPL volumes reported by multiple studies. Due to the nonlinear relationship between radius and volume, this corresponds to a mean IPL radius probably well below 8 mm. In our simulation we use a cautious assumption of 3, 5, and 7 mm in order to highlight the impact of intrafraction motion on smaller targets.

Sing et al. \[[@CR1]\] found that four IPLs in three patients were successfully targeted with a 3 mm margin. In our simulation, using a margin of 2 mm or more ensures at least 90% of prescribed dose to the entire IPL volume.

A large and recent study \[[@CR7]\] reports that 284 patients with an additional SIB of 95 Gy to the IPL did not differ in toxicity from the base group of 287 patients receiving only 77 Gy to the entire prostate. Other studies show similar levels of tolerance \[[@CR5], [@CR6], [@CR8]\]. Our data shows that the average displacement of the prostate is 1.3 mm. 95% of the time, the prostate remains within 4.3 mm of its initial position, notably without any mitigation (such as online correction of the table position or the multi leaf collimator). While this means that the SIB is not always centered on the IPL, the SIB will hit prostate tissue predominantly, depending on the location of the IPL within the prostate. Our simulation indicates that the IPL would receive the majority of the SIB in case of an IPL radius of at least 8 mm and a safety margin of at most 2 mm. Without safety margin (reducing the coverage of the IPL by the SIB), the coverage of the SIB by the IPL rises to 73% resp. 87% in case of an IPL radius of 3 mm resp. 7 mm.

In a planning study with and without simulated intrafraction motion \[[@CR10]\] a safety margin of 7 mm was found to make both sequential or simultaneous boosts feasible. This is in agreement with our simulation showing that already a safety margin of 5 mm will yield 97% of the dose to 100% of the IPL volume.

Another planning study \[[@CR9]\] concludes that even a hypofractionated SIB is feasible but 'requires small margins needing intrafraction motion tracking'. This is in agreement with our simulation indicating that a safety margin of only around 2 mm might be a good compromise in terms of dose delivery to the IPL and toxicity. From other work \[[@CR19], [@CR20]\], we agree that online tracking and correction is the preferred approach to counter intrafraction motion.

However, there was considerable variability between patients. On the one hand, in a patient with little motility, an average displacement of the prostate of only 0.5 mm meant that 2 mm margins would have covered the complete lesion volume with at least 98% of the dose. On the other hand, in a patient with especially high motility, an average displacement of the prostate of 2.5 mm meant that 2 mm margins would have ensured only 72% of the total dose to 100% of the lesion volume. Here even a margin of 5 mm would ensure coverage with 90% of the prescribed dose to 69% of the volume of a lesion of radius 7 mm.

There are a couple of limitations to our study. Foremost, our simulation takes the recorded trajectories as ground truth and does not consider noise on top of them. Realistic margins will take all sources of error into account. The simplest way to do so (albeit not technically correct) would be to treat the intra-fraction motion as one of several sources of variance and simply add those up. The caveat lies in the fact that while other sources of error have constant variance, the variance of intra-fraction increases linearly in time \[[@CR18], [@CR19]\]. This leads to non-Gaussian kernels of dose convolution \[[@CR21]\]. This also means that standard optimal margin recipes for inter-fractional motion, in so far as they assume a Gaussian distribution of displacements \[[@CR22]\], are not perfectly valid for intra-fraction motion.

Also, our simulation does not take any interference between the motion of the apparatus (e.g. collimator leaves) and the motion of the prostate into account. The simulation simply assumes a constant and perfectly spherical dose distribution. We also did not consider any effects of target rotation or deformation. The IPL is assumed to be a constant and perfectly spherical volume. In comparison to more realistic 4D dose reconstruction techniques \[[@CR14], [@CR23]\] our approach is a simplification dictated by available data, i.e. tracking of the prostate center only.

Furthermore, an interesting question which is out of the scope of this simulation is the question how much dose a neighboring organ at risk receives due to intra-fraction motion. On the one hand, one could use our model for a simple calculation by looking at two spheres at a certain initial distance. However, a sphere is already an idealization of an IPL and is even less so a suitable proxy for the shape of organs at risk such as e.g. the rectum.

Conclusion {#Sec12}
==========

While sometimes the prostate strayed far from its initial position, on average over all fractions and patients, the dose coverage would have been acceptable even for small target volumes such as IPLs of radius 3 to 7 mm and narrow fields. Moderate safety margins of 2 mm could have ensured a delivery of 90% or more of the SIB dose to the IPL in the average patient. In this case, SIB volume would have been considerably larger than IPL volume, but still considerably smaller than the overall PTV of the prostate. However, there is considerable variability between patients, with some extreme cases requiring larger margins still for a satisfactory dose coverage.

Additional file
===============

 {#Sec13}

Additional file 1:**Table S5.** DVH, volume in % of IPL volume as a function of dose in % of nominal SIB dose. (DOCX 26 kb)

4DUS

:   4D ultrasound; ultrasound imaging resolving both volume (3D) and time (1D)

DVH

:   Dose volume histogram

IPL

:   Intraprostatic lesion

SIB

:   Simultaneous integrated boost
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